Current Drug Targets - CNS & Neurological Disorders
Continued as: CNS & Neurological Disorders - Drug Targets
Volume , Issues,
ISSN: 1568-007X (Online)
ISSN: 1568-007X (Print)
This journal supports open access
ISSN: 1568-007X (Online)
ISSN: 1568-007X (Print)
This journal supports open access
Contents
Current Drug Targets - CNS & Neurological Disorders , Volume 1 - Number 1
Direct and Indirect Modulation of the N-Methyl D-Aspartate Receptor: Potential for the Development of Novel Antipsychotic Therapies
, 1(1): 1 - 16M. J. Marino and P. Jeffrey Conn
DOI: 10.2174/1568007023339544
Multiple Sclerosis: Emerging Opportunities for Therapeutic Intervention
, 1(1): 17 - 30C. F. Evans and L. P. Shriver
DOI: 10.2174/1568007023339526
Targeting the JNK Pathway for Therapeutic Benefit in CNS Disease
, 1(1): 31 - 49Donna Bozyczko-Coyne, Michael S. Saporito and Robert L. Hudkins
DOI: 10.2174/1568007023339472
Oiling the Pipeline: The Path from Genomics to Drug Discovery for Brain Disease
, 1(1): 51 - 58Christopher J. Winrow and Carrolee Barlow
DOI: 10.2174/1568007023339517
Small Molecule Trk Receptor Agonists and Other Neurotrophic Factor Mimetics
, 1(1): 59 - 80Scott J. Pollack and Sarah J. Harper
DOI: 10.2174/1568007023339490
Recent Advances in the Modulation of Voltage-Gated Ion Channels for the Treatment of Epilepsy
, 1(1): 81 - 104Nicholas D.P. Cosford, Peter T. Meinke, Kenneth A. Stauderman and Stephen D. Hess
DOI: 10.2174/1568007023339463
Constitutively Activated G Protein-Coupled Receptors: A Novel Approach to CNS Drug Discovery
, 1(1): 105 - 121Frederique D.P. Menzaghi, Dominic P. Behan and Derek T. Chalmers
DOI: 10.2174/1568007023339508
Webmaster Contact: info@benthamscience.net